Multiple Myeloma FAQs and Talking Points

Multiple myeloma (MM) is a common hematologic malignancy, and because of new treatments, survival rates for patients with this diagnosis are improving. Nurses are essential for patient care and education, especially with treatment advances for MM and the volume of novel therapies being approved. The downloadable resource found via the "Download PDF" button below provides a list of frequently asked questions about MM related to foundational knowledge, care coordination, and evidence-based practice, with straightforward talking points for reference.